欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0342/004
药品名称Co-Dalnessa 8 mg/ 2.5 mg/ 5 mg
活性成分
    • amlodipine besilate 5.0 mg
    • indapamide 2.5 mg
    • perindopril tert-butylamine 8.0 mg
剂型Tablet
上市许可持有人Krka, d.d., Novo mesto
参考成员国 - 产品名称Hungary (HU)
CO-DALNESSA 8 mg/5 mg/2,5 mg tabletta
互认成员国 - 产品名称
    • Poland (PL)
      Co-Amlessa
    • Latvia (LV)
      Co-Amlessa 8 mg/5 mg/2,5 mg tabletes
    • Lithuania (LT)
      Co-Amlessa 8 mg/5 mg/2,5 mg/ tabletės
    • Estonia (EE)
      CO-DALNESSA
    • Bulgaria (BG)
      Co-Amlessa
    • Romania (RO)
      Co-Amlessa 8 mg/ 2.5 mg/ 5 mg comprimate
    • Slovakia (SK)
      Co-Amlessa 8 mg/5 mg/2,5 mg tablety
    • Czechia (CZ)
      Amlecombi 8 mg/ 5 mg/ 2.5 mg tablety
    • Slovenia (SI)
许可日期2013/10/23
最近更新日期2024/03/19
药物ATC编码
    • C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase